648 related articles for article (PubMed ID: 33847835)
1. SKI activates the Hippo pathway via LIMD1 to inhibit cardiac fibroblast activation.
Landry NM; Rattan SG; Filomeno KL; Meier TW; Meier SC; Foran SJ; Meier CF; Koleini N; Fandrich RR; Kardami E; Duhamel TA; Dixon IMC
Basic Res Cardiol; 2021 Apr; 116(1):25. PubMed ID: 33847835
[TBL] [Abstract][Full Text] [Related]
2. The Ski-Zeb2-Meox2 pathway provides a novel mechanism for regulation of the cardiac myofibroblast phenotype.
Cunnington RH; Northcott JM; Ghavami S; Filomeno KL; Jahan F; Kavosh MS; Davies JJ; Wigle JT; Dixon IM
J Cell Sci; 2014 Jan; 127(Pt 1):40-9. PubMed ID: 24155330
[TBL] [Abstract][Full Text] [Related]
3. Ski drives an acute increase in MMP-9 gene expression and release in primary cardiac myofibroblasts.
Landry N; Kavosh MS; Filomeno KL; Rattan SG; Czubryt MP; Dixon IMC
Physiol Rep; 2018 Nov; 6(22):e13897. PubMed ID: 30488595
[TBL] [Abstract][Full Text] [Related]
4. Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis.
Liu F; Lagares D; Choi KM; Stopfer L; Marinković A; Vrbanac V; Probst CK; Hiemer SE; Sisson TH; Horowitz JC; Rosas IO; Fredenburgh LE; Feghali-Bostwick C; Varelas X; Tager AM; Tschumperlin DJ
Am J Physiol Lung Cell Mol Physiol; 2015 Feb; 308(4):L344-57. PubMed ID: 25502501
[TBL] [Abstract][Full Text] [Related]
5. MiR-34a/miR-93 target c-Ski to modulate the proliferaton of rat cardiac fibroblasts and extracellular matrix deposition in vivo and in vitro.
Zhang C; Zhang Y; Zhu H; Hu J; Xie Z
Cell Signal; 2018 Jun; 46():145-153. PubMed ID: 29551367
[TBL] [Abstract][Full Text] [Related]
6. Ski regulates Hippo and TAZ signaling to suppress breast cancer progression.
Rashidian J; Le Scolan E; Ji X; Zhu Q; Mulvihill MM; Nomura D; Luo K
Sci Signal; 2015 Feb; 8(363):ra14. PubMed ID: 25670202
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast mechanosensing, SKI and Hippo signaling and the cardiac fibroblast phenotype: Looking beyond TGF-β.
Landry NM; Dixon IMC
Cell Signal; 2020 Dec; 76():109802. PubMed ID: 33017619
[TBL] [Abstract][Full Text] [Related]
8. Loss of Yap/Taz in cardiac fibroblasts attenuates adverse remodelling and improves cardiac function.
Mia MM; Cibi DM; Ghani SABA; Singh A; Tee N; Sivakumar V; Bogireddi H; Cook SA; Mao J; Singh MK
Cardiovasc Res; 2022 Jun; 118(7):1785-1804. PubMed ID: 34132780
[TBL] [Abstract][Full Text] [Related]
9. Multiscale Analysis of Extracellular Matrix Remodeling in the Failing Heart.
Perestrelo AR; Silva AC; Oliver-De La Cruz J; Martino F; Horváth V; Caluori G; Polanský O; Vinarský V; Azzato G; de Marco G; Žampachová V; Skládal P; Pagliari S; Rainer A; Pinto-do-Ó P; Caravella A; Koci K; Nascimento DS; Forte G
Circ Res; 2021 Jan; 128(1):24-38. PubMed ID: 33106094
[TBL] [Abstract][Full Text] [Related]
10. Dynamic Chromatin Targeting of BRD4 Stimulates Cardiac Fibroblast Activation.
Stratton MS; Bagchi RA; Felisbino MB; Hirsch RA; Smith HE; Riching AS; Enyart BY; Koch KA; Cavasin MA; Alexanian M; Song K; Qi J; Lemieux ME; Srivastava D; Lam MPY; Haldar SM; Lin CY; McKinsey TA
Circ Res; 2019 Sep; 125(7):662-677. PubMed ID: 31409188
[TBL] [Abstract][Full Text] [Related]
11. Notch3 Ameliorates Cardiac Fibrosis After Myocardial Infarction by Inhibiting the TGF-β1/Smad3 Pathway.
Zhang M; Pan X; Zou Q; Xia Y; Chen J; Hao Q; Wang H; Sun D
Cardiovasc Toxicol; 2016 Oct; 16(4):316-24. PubMed ID: 26487518
[TBL] [Abstract][Full Text] [Related]
12. Acetylcytidine modification of Amotl1 by N-acetyltransferase 10 contributes to cardiac fibrotic expansion in mice after myocardial infarction.
Wang XX; Zhao YM; Zhang QY; Zhao JX; Yin DH; Zhang ZZ; Jin XY; Li SN; Ji HY; Chen HY; Guo XF; Yu Y; Ma WY; Yan H; Li H; Ou-Yang QM; Pan ZW; Liang HH; Wang N; Chen W; Cai BZ; Liu Y
Acta Pharmacol Sin; 2024 Jul; 45(7):1425-1437. PubMed ID: 38839936
[TBL] [Abstract][Full Text] [Related]
13. Gingival proteomics reveals the role of TGF beta and YAP/TAZ signaling in Raine syndrome fibrosis.
Costa CRR; Chalgoumi R; Baker A; Guillou C; Yamaguti PM; Simancas Escorcia V; Abbad L; Amorin BR; de Lima CL; Cannaya V; Benassarou M; Berdal A; Chatziantoniou C; Cases O; Cosette P; Kozyraki R; Acevedo AC
Sci Rep; 2024 Apr; 14(1):9497. PubMed ID: 38664418
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of yes-associated protein/YAP and transcriptional coactivator with PDZ-binding motif/TAZ activates intestinal fibroblasts to promote intestinal obstruction in Crohn's disease.
Ou W; Xu W; Liu F; Guo Y; Huang Z; Feng T; Liu CY; Du P
EBioMedicine; 2021 Jul; 69():103452. PubMed ID: 34186485
[TBL] [Abstract][Full Text] [Related]
15. Antifibrotic properties of c-Ski and its regulation of cardiac myofibroblast phenotype and contractility.
Cunnington RH; Wang B; Ghavami S; Bathe KL; Rattan SG; Dixon IM
Am J Physiol Cell Physiol; 2011 Jan; 300(1):C176-86. PubMed ID: 20943957
[TBL] [Abstract][Full Text] [Related]
16. GPCR-mediated YAP/TAZ inactivation in fibroblasts via EPAC1/2, RAP2C, and MAP4K7.
Choi KM; Haak AJ; Diaz Espinosa AM; Cummins KA; Link PA; Aravamudhan A; Wood DK; Tschumperlin DJ
J Cell Physiol; 2021 Nov; 236(11):7759-7774. PubMed ID: 34046891
[TBL] [Abstract][Full Text] [Related]
17. CTRP3 attenuates post-infarct cardiac fibrosis by targeting Smad3 activation and inhibiting myofibroblast differentiation.
Wu D; Lei H; Wang JY; Zhang CL; Feng H; Fu FY; Li L; Wu LL
J Mol Med (Berl); 2015 Dec; 93(12):1311-25. PubMed ID: 26138247
[TBL] [Abstract][Full Text] [Related]
18. Chronic expression of Ski induces apoptosis and represses autophagy in cardiac myofibroblasts.
Zeglinski MR; Davies JJ; Ghavami S; Rattan SG; Halayko AJ; Dixon IM
Biochim Biophys Acta; 2016 Jun; 1863(6 Pt A):1261-8. PubMed ID: 27039037
[TBL] [Abstract][Full Text] [Related]
19. Soluble transforming growth factor-beta1 receptor II might inhibit transforming growth factor-beta-induced myofibroblast differentiation and improve ischemic cardiac function after myocardial infarction in rats.
Lian R; Chen Y; Xu Z; Zhang X
Coron Artery Dis; 2010 Sep; 21(6):369-77. PubMed ID: 20613497
[TBL] [Abstract][Full Text] [Related]
20. Novel factors that activate and deactivate cardiac fibroblasts: A new perspective for treatment of cardiac fibrosis.
de Oliveira Camargo R; Abual'anaz B; Rattan SG; Filomeno KL; Dixon IMC
Wound Repair Regen; 2021 Jul; 29(4):667-677. PubMed ID: 34076932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
